MicroRNAs in Ovarian Cancer

Human Pathology

Volumn 46, Issue 9, 2015, Pages 1245-1256

  Katz, Betina ^a   Tropé, Claes G ^a,b   Reich, Reuven ^c,d   Davidson, Ben ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Chemotherapy; Diagnosis; MicroRNA; Ovarian carcinoma; Prognosis

Indexed keywords

MICRORNA; TUMOR MARKER;

ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; EPITHELIAL MESENCHYMAL TRANSITION; EXOSOME; FEMALE; GENE EXPRESSION PROFILING; GENE TARGETING; HUMAN; MOLECULAR DIAGNOSIS; NONHUMAN; OVARIAN TISSUE; OVARY CANCER; OVARY CARCINOMA; ANIMAL; CARCINOMA; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULARLY TARGETED THERAPY; OVARIAN NEOPLASMS; PATHOLOGY; PERSONALIZED MEDICINE; PREDICTIVE VALUE; PROGNOSIS;

ANIMALS; CARCINOMA; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDIVIDUALIZED MEDICINE; MICRORNAS; MOLECULAR DIAGNOSTIC TECHNIQUES; MOLECULAR TARGETED THERAPY; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84940459782     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2015.06.013     Document Type: Article

References (107)

1. B.R. Cullen Transcription and processing of human microRNA precursors Mol Cell 16 2004 861 865
2. J. Permuth-Wey, Z. Chen, Y.Y. Tsai, and et al. Ovarian Cancer Association Consortium (OCAC). MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium Cancer Epidemiol Biomarkers Prev 20 2011 1793 1797
3. A.J. Pratt, and I.J. MacRae The RNA-induced silencing complex: a versatile gene-silencing machine J Biol Chem 284 2009 17897 17901
4. A. Grimson, K.K. Farh, W.K. Johnston, P. Garrett-Engele, L.P. Lim, and D.P. Bartel MicroRNA targeting specificity in mammals: determinants beyond seed pairing Mol Cell 27 2007 91 105
5. G.A. Calin, C.D. Dumitru, M. Shimizu, and et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia Proc Natl Acad Sci U S A 99 2002 15524 15529
6. L. Zhang, S. Volinia, T. Bonome, and et al. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer Proc Natl Acad Sci U S A 105 2008 7004 7009
7. Cancer Genome Atlas Research Network Integrated genomic analyses of ovarian carcinoma Nature 474 2011 609 615
8. J.L. Bearfoot, D.Y. Choong, K.L. Gorringe, and I.G. Campbell Genetic analysis of cancer-implicated MicroRNA in ovarian cancer Clin Cancer Res 14 2008 7246 7250
9. G.L. Ryland, J.L. Bearfoot, M.A. Doyle, and et al. MicroRNA genes and their target 3'-untranslated regions are infrequently somatically mutated in ovarian cancers PLoS One 7 2012 e35805
10. S.W. Shahab, L.V. Matyunina, C.G. Hill, and et al. The effects of MicroRNA transfections on global patterns of gene expression in ovarian cancer cells are functionally coordinated BMC Med Genomics 5 2012 33
11. E.J. Nam, H. Yoon, S.W. Kim, and et al. MicroRNA expression profiles in serous ovarian carcinoma Clin Cancer Res 14 2008 2690 2695
12. M.V. Iorio, R. Visone, G. Di Leva, and et al. MicroRNA signatures in human ovarian cancer Cancer Res 67 2007 8699 8707
13. S.K. Wyman, R.K. Parkin, P.S. Mitchell, and et al. Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries PLoS One 4 2009 e5311
14. E. Calura, R. Fruscio, L. Paracchini, and et al. MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities Clin Cancer Res 19 2013 4114 4123
15. B. Vilming Elgaaen, O.K. Olstad, K.B. Haug, and et al. Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker BMC Cancer 14 2014 80
16. R.J. Flavin, P.C. Smyth, S.P. Finn, and et al. Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patients Mod Pathol 21 2008 676 684
17. W.M. Merritt, Y.G. Lin, L.Y. Han, and et al. Dicer, Drosha, and outcomes in patients with ovarian cancer N Engl J Med 359 2008 2641 2650
18. G. Pampalakis, E.P. Diamandis, D. Katsaros, and G. Sotiropoulou Down-regulation of dicer expression in ovarian cancer tissues Clin Biochem 43 2010 324 327
19. K.E. Resnick, H. Alder, J.P. Hagan, D.L. Richardson, C.M. Croce, and D.E. Cohn The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform Gynecol Oncol 112 2009 55 59
20. S.F. Hausler, A. Keller, P.A. Chandran, and et al. Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening Br J Cancer 103 2010 693 700
21. H. Zheng, L. Zhang, Y. Zhao, and et al. Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer PLoS One 8 2013 e77853
22. C.W. Kan, V.M. Howell, M.A. Hahn, and D.J. Marsh Genomic alterations as mediators of miRNA dysregulation in ovarian cancer Genes Chromosomes Cancer 54 2015 1 19
23. Y.W. Chung, H.S. Bae, J.Y. Song, and et al. Detection of microRNA as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patients Int J Gynecol Cancer 23 2013 673 679
24. I. Shapira, M. Oswald, J. Lovecchio, and et al. Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes Br J Cancer 110 2014 976 983
25. R. Langhe, L. Norris, F.A. Saadeh, and et al. A novel serum microRNA panel to discriminate benign from malignant ovarian disease Cancer Lett 356 2015 628 636
26. L. Záveský, E. Jandáková, R. Turyna, and et al. Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study Pathol Oncol Res 2015 [Epub ahead of print]
27. J.A. Weber, D.H. Baxter, S. Zhang, and et al. The microRNA spectrum in 12 body fluids Clin Chem 56 2010 1733 1741
28. H. Valadi, K. Ekstrom, A. Bossios, M. Sjostrand, J.J. Lee, and J.O. Lotvall Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells Nat Cell Biol 9 2007 654 659
29. D.D. Taylor, and C. Gercel-Taylor MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer Gynecol Oncol 110 2008 13 21
30. O. Vaksman, C. Trope, B. Davidson, and R. Reich Exosome-derived miRNAs and ovarian carcinoma progression Carcinogenesis 35 2014 2113 2120
31. M. Kobayashi, C. Salomon, J. Tapia, S.E. Illanes, M.D. Mitchell, and G.E. Rice Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200 J Transl Med 12 2014 4
32. A. Heravi-Moussavi, M.S. Anglesio, S.W. Cheng, and et al. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers N Engl J Med 366 2012 234 242
33. O. Vaksman, H.T. Stavnes, J. Kaern, C.G. Trope, B. Davidson, and R. Reich miRNA profiling along tumour progression in ovarian carcinoma J Cell Mol Med 15 2011 1593 1602
34. O. Vaksman, T.E. Hetland, C.G. Trope, R. Reich, and B. Davidson Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma Hum Pathol 43 2012 2062 2069
35. S. Vang, H.T. Wu, A. Fischer, and et al. Identification of ovarian cancer metastatic miRNAs PLoS One 8 2013 e58226
36. A. Laios, S. O'Toole, R. Flavin, and et al. Potential role of miR-9 and miR-223 in recurrent ovarian cancer Mol Cancer 7 2008 35
37. R. Bhattacharya, M. Nicoloso, R. Arvizo, and et al. MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer Cancer Res 69 2009 9090 9095
38. C. Polytarchou, D. Iliopoulos, M. Hatziapostolou, and et al. Akt2 regulates all Akt isoforms and promotes resistance to hypoxia through induction of miR-21 upon oxygen deprivation Cancer Res 71 2011 4720 4731
39. Y. Hirata, N. Murai, N. Yanaihara, and et al. MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma BMC Cancer 14 2014 799
40. R. Cappellesso, A. Tinazzi, T. Giurici, and et al. Programmed cell death 4 and microRNA 21 inverse expression is maintained in cells and exosomes from ovarian serous carcinoma effusions Cancer Cytopathol 122 2014 685 693
41. W. Shen, M. Song, J. Liu, and et al. MiR-26a promotes ovarian cancer proliferation and tumorigenesis PLoS One 9 2014 e86871
42. F. Dai, Y. Zhang, and Y. Chen Involvement of miR-29b signaling in the sensitivity to chemotherapy in patients with ovarian carcinoma Hum Pathol 45 2014 1285 1293
43. W. Jia, J.O. Eneh, S. Ratnaparkhe, M.K. Altman, and M.M. Murph MicroRNA-30c-2∗expressed in ovarian cancer cells suppresses growth factor-induced cellular proliferation and downregulates the oncogene BCL9 Mol Cancer Res 9 2011 1732 1745
44. D.C. Corney, C.I. Hwang, A. Matoso, and et al. Frequent downregulation of miR-34 family in human ovarian cancers Clin Cancer Res 16 2010 1119 1128
45. E.G. Seviour, V. Sehgal, Y. Lu, and et al. Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer Oncogene 2015 10.1038/onc.2014.469 [Epub ahead of print]
46. K.D. Cowden Dahl, R. Dahl, J.N. Kruichak, and L.G. Hudson The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells Neoplasia 11 2009 1208 1215
47. Y. Guan, H. Yao, Z. Zheng, G. Qiu, and K. Sun MiR-125b targets BCL3 and suppresses ovarian cancer proliferation Int J Cancer 128 2011 2274 2283
48. Y.M. Yeh, C.M. Chuang, K.C. Chao, and L.H. Wang MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1alpha Int J Cancer 133 2013 867 878
49. A. Parikh, C. Lee, P. Joseph, and et al. microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition Nat Commun 5 2014 2977
50. Z. Liu, J. Liu, M.F. Segura, and et al. MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma J Pathol 228 2012 204 215
51. H.P. Joshi, I.V. Subramanian, E.K. Schnettler, and et al. Dynamin 2 along with microRNA-199a reciprocally regulate hypoxia-inducible factors and ovarian cancer metastasis Proc Natl Acad Sci U S A 111 2014 5331 5336
52. A. Bendoraite, E.C. Knouf, K.S. Garg, and et al. Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition Gynecol Oncol 116 2010 117 125
53. D. Yang, Y. Sun, L. Hu, and et al. Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer Cancer Cell 23 2013 186 199
54. Y. Sun, L. Hu, H. Zheng, and et al. MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer J Pathol 235 2015 25 36
55. G. Liu, Y. Sun, P. Ji, and et al. MiR-506 suppresses proliferation and induces senescence by directly targeting the CDK4/6-FOXM1 axis in ovarian cancer J Pathol 233 2014 308 318
56. N. Dahiya, C.A. Sherman-Baust, T.L. Wang, and et al. MicroRNA expression and identification of putative miRNA targets in ovarian cancer PLoS One 3 2008 e2436
57. L.K. Mullany, H.Y. Fan, Z. Liu, and et al. Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo Oncogene 30 2011 3522 3536
58. C.J. Creighton, M.D. Fountain, Z. Yu, and et al. Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers Cancer Res 70 2010 1906 1915
59. E.C. Knouf, K. Garg, J.D. Arroyo, and et al. An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription Nucleic Acids Res 40 2012 499 510
60. Q. Wu, R. Guo, M. Lin, B. Zhou, and Y. Wang MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2 Gynecol Oncol 122 2011 149 154
61. J. Wu, Z. Liu, C. Shao, and et al. HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes Cancer Res 71 2011 349 359
62. A.K. Mitra, M. Zillhardt, Y. Hua, and et al. MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer Cancer Discov 2 2012 1100 1108
63. C.V. Pecot, R. Rupaimoole, D. Yang, and et al. Tumour angiogenesis regulation by the miR-200 family Nat Commun 4 2013 2427
64. S.A. Cannistra Cancer of the ovary N Engl J Med 351 2004 2519 2529
65. C. Sun, N. Li, Z. Yang, and et al. miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition J Natl Cancer Inst 105 2013 1750 1758
66. T. Mitamura, H. Watari, L. Wang, and et al. Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET Oncogenesis 2 2013 e40
67. X. Fu, J. Tian, L. Zhang, Y. Chen, and Q. Hao Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells FEBS Lett 586 2012 1279 1286
68. J.H. Huh, T.H. Kim, K. Kim, and et al. Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer Br J Cancer 109 2013 452 461
69. M.T. van Jaarsveld, J. Helleman, A.W. Boersma, and et al. miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells Oncogene 32 2013 4284 4293
70. Y.Q. Wang, R.D. Guo, R.M. Guo, W. Sheng, and L.R. Yin MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas J Cell Biochem 114 2013 1464 1473
71. W. Cheng, T. Liu, X. Wan, Y. Gao, and H. Wang MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells FEBS J 279 2012 2047 2059
72. M.X. Liu, M.K. Siu, S.S. Liu, J.W. Yam, H.Y. Ngan, and D.W. Chan Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer Oncotarget 5 2014 944 958
73. D.M. Cittelly, I. Dimitrova, E.N. Howe, and et al. Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel Mol Cancer Ther 11 2012 2556 2565
74. H. Yang, W. Kong, L. He, and et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN Cancer Res 68 2008 425 433
75. G. Ye, G. Fu, S. Cui, and et al. MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance J Cell Sci 124 2011 359 368
76. J.K. Chan, T.K. Kiet, K. Blansit, and et al. MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer Gynecol Oncol 133 2014 568 574
77. F. Furlong, P. Fitzpatrick, S. O'Toole, and et al. Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer J Pathol 226 2012 746 755
78. A. Vecchione, B. Belletti, F. Lovat, and et al. A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis Proc Natl Acad Sci U S A 110 2013 9845 9850
79. B. Boyerinas, S.M. Park, A.E. Murmann, and et al. Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1 Int J Cancer 130 2012 1787 1797
80. N. Wei, S.S. Liu, K.K. Chan, and H.Y. Ngan Tumour suppressive function and modulation of programmed cell death 4 (PDCD4) in ovarian cancer PLoS One 7 2012 e30311
81. Y.W. Kim, E.Y. Kim, D. Jeon, and et al. Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells Drug Des Devel Ther 8 2014 293 314
82. R. Flavin, P. Smyth, C. Barrett, and et al. miR-29b expression is associated with disease-free survival in patients with ovarian serous carcinoma Int J Gynecol Cancer 19 2009 641 647
83. H. Lee, C.S. Park, G. Deftereos, and et al. MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features World J Surg Oncol 10 2012 174
84. N. Li, S. Kaur, J. Greshock, and et al. A combined array-based comparative genomic hybridization and functional library screening approach identifies mir-30d as an oncomir in cancer Cancer Res 72 2012 154 164
85. D. Reimer, M. Hubalek, H. Kiefel, and et al. Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer Oncogene 30 2011 4038 4049
86. C.H. Lee, S. Subramanian, A.H. Beck, and et al. MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary PLoS One 4 2009 e7314
87. D.X. Peng, M. Luo, L.W. Qiu, Y.L. He, and X.F. Wang Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer Oncol Rep 27 2012 1238 1244
88. C. Ivan, W. Hu, J. Bottsford-Miller, and et al. Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer Gynecol Oncol 128 2013 506 511
89. B.D. McMillen, M.M. Aponte, Z. Liu, and et al. Expression analysis of MIR182 and its associated target genes in advanced ovarian carcinoma Mod Pathol 25 2012 1644 1653
90. A. Chao, C.Y. Lin, Y.S. Lee, and et al. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2 Oncogene 31 2012 764 775
91. X. Hu, D.M. Macdonald, P.C. Huettner, and et al. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer Gynecol Oncol 114 2009 457 464
92. B. Mateescu, L. Batista, M. Cardon, and et al. miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response Nat Med 17 2011 1627 1635
93. S. Marchini, D. Cavalieri, R. Fruscio, and et al. Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections Lancet Oncol 12 2011 273 285
94. S. Wang, X. Zhao, J. Wang, and et al. Upregulation of microRNA-203 is associated with advanced tumor progression and poor prognosis in epithelial ovarian cancer Med Oncol 30 2013 681
95. F. Hong, Y. Li, Y. Xu, and L. Zhu Prognostic significance of serum microRNA-221 expression in human epithelial ovarian cancer J Int Med Res 41 2013 64 71
96. K. Wurz, R.L. Garcia, B.A. Goff, and et al. MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B, CDKNIC and overall survival Genes Chromosomes Cancer 49 2010 577 584
97. J. Cao, J. Cai, D. Huang, and et al. miR-335 represents an independent prognostic marker in epithelial ovarian cancer Am J Clin Pathol 141 2014 437 442
98. K.K. Shih, L.X. Qin, E.J. Tanner, and et al. A microRNA survival signature (MiSS) for advanced ovarian cancer Gynecol Oncol 121 2011 444 450
99. X. Yu, X. Zhang, T. Bi, and et al. MiRNA expression signature for potentially predicting the prognosis of ovarian serous carcinoma Tumour Biol 34 2013 3501 3508
100. T.H. Kim, Y.K. Kim, Y. Kwon, and et al. Deregulation of miR-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours Histopathology 57 2010 734 743
101. K.T. Lin, Y.M. Yeh, C.M. Chuang, and et al. Glucocorticoids mediate induction of microRNA-708 to suppress ovarian cancer metastasis through targeting Rap1B Nat Commun 6 2015 5917
102. R. Eitan, M. Kushnir, G. Lithwick-Yanai, and et al. Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients Gynecol Oncol 114 2009 253 259
103. Z. Tang, G.S. Ow, J.P. Thiery, A.V. Ivshina, and V.A. Kuznetsov Meta-analysis of transcriptome reveals let-7b as an unfavorable prognostic biomarker and predicts molecular and clinical subclasses in high-grade serous ovarian carcinoma Int J Cancer 134 2014 306 318
104. A. Faggad, J. Budczies, O. Tchernitsa, and et al. Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression J Pathol 220 2010 382 391
105. W. Zhang, Y. Liu, N. Sun, and et al. Integrating genomic, epigenomic, and transcriptomic features reveals modular signatures underlying poor prognosis in ovarian cancer Cell Rep 4 2013 542 553
106. T.Z. Tan, Q.H. Miow, R.Y. Huang, and et al. Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer EMBO Mol Med 5 2013 983 998
107. M. Nishimura, E.J. Jung, M.Y. Shah, and et al. Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment Cancer Discov 3 2013 1302 1315